CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the introduction of a new benchtop instrument, Countess™ automated cell counter, which offers a new method of automated cell counting to replace manual cell counting using a glass hemocytometer.
